3644 results for «2704»
3644 results
PCR e-Course 2020 Closing Ceremony: reinventing education in interventional cardiovascular medicine!
28 Jun 2020 – From PCR e-Course 2020
On behalf of the Core Team and the 271 e-Faculty members, Davide Capodanno, Jean Fajadet and William Wijns thank those who attended and participated in - as well as contributed to - PCR e-Course 2020. At a time when exchange with peers and extended networks like...
EuroPCR 2021 Clinical Research - Waiting for a new meta-analysis of revascularisation versus medical therapy for chronic coronary syndromes: what should we be focusing on?
12 May 2021 – From EuroPCR 2021
Revascularisation vs. medical therapy alone for chronic coronary syndromes: has the issue been settled ? Follow this PCR Clinical Research episode to understand the new findings from the latest meta-analysis!
PCR Clinical Research 2021 - Waiting for EBC-MAIN, a randomised trial of stenting strategies for the treatment of LM coronary bifurcation disease
28 Apr 2021 – From EuroPCR 2021
How are you going to treat your next left main lesion involving both LAD and CX ostia: provisional vs. upfront two-stent strategy ? Follow this PCR Clinical Research episode for more news on the EBC MAIN trial!
PCR Clinical Research - Late breaking science at EuroPCR 2021:...
EuroIntervention - Most cited papers of the year 2020
18 May 2021 – From EuroPCR 2021
Thanks to this session, which was originally presented during EuroPCR 2021, by D. Capodanno, Editor-in-chief, and N. Gonzalo & D. Mylotte, deputy editors, discover the top 3 most cited EuroIntervention Journal papers in 2020, and hear the reaction of the winner, interviewed for the occasion.
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques
22 May 2025 – From EuroPCR 2025
Unveil the potential of novel imaging techniques in identifying hidden atherosclerosis and silent inflammation. This session discusses the role of perivascular adipose tissue in plaque development, highlights advances in early inflammation detection, and explores clinical management of patients with athero-inflammation beyond traditional stenting options.
Insight from new evidence for complex PCI: value of imaging (CHIP IVUS) and left ventricular support (CHIP BCIS 3)
21 May 2026 – From EuroPCR 2026
This session reviews the impact of recent evidence on complex PCI, highlighting the value of intracoronary imaging (CHIP IVUS trial) and left ventricular assist devices (CHIP BCIS 3 trial). Through case discussions, participants reflect on how these innovations influence daily clinical practice and enhance procedural planning...
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
EBC MAIN - the European Bifurcation Club left main coronary bifurcation study
19 May 2021 – From EuroPCR 2021
In this session, originally presented during EuroPCR 2021, discover the EBC Main study and follow the in-depth discussion lead with the PCR clinical research team about the results of this important trial comparing stepwise provisional versus systematic dual stenting strategies.
Alain Cribier EuroIntervention Award
16 Nov 2025 – From PCR London Valves 2025
This session honors the legacy and contributions of Alain Cribier through the EuroIntervention Award, recognizing excellence and innovation in interventional cardiology. It reflects on the advancements inspired by Dr. Cribier's pioneering work and highlights key achievements in the field.
Meta-analysis of elective coronary revascularization vs medical therapy alone
18 May 2021 – From EuroPCR 2021
This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
What did 2022 tell us so far in interventions? Essential publications from the EuroIntervention Journal and the European Heart Journal
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session lists the best EIJ and EHJ publications in terms of coronary interventions, intravascular imaging and physiology, interventions for mitral and tricuspid valve disease, and interventions for aortic valve disease.
Antithrombotics in practice after PCI: from evidence to individual patient management
17 May 2022 – From EuroPCR 2022
In this session, compare the case of a typical ACS PCI patient with two cases with chronic settings to see whether there are other options to be considered as far as antithrombotic strategy is concerned.
TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
Challenging scenarios: bioprosthetic valve dysfunction
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores contemporary PCI strategies through the concept of stentless intervention using the Bioadaptor device in complex coronary disease.
It highlights the bioadaptive design features of Bioadaptor and reviews the supporting clinical evidence, with a focus on how this technology may influence procedural outcomes.
The...
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
